Daniella Beckman
2022
In 2022, Daniella Beckman earned a total compensation of $1.5M as Chief Financial Officer at Tango Therapeutics, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,614 |
|---|---|
| Option Awards | $897,750 |
| Salary | $425,100 |
| Other | $2,415 |
| Total | $1,516,879 |
Beckman received $897.8K in option awards, accounting for 59% of the total pay in 2022.
Beckman also received $191.6K in non-equity incentive plan, $425.1K in salary and $2.4K in other compensation.
Rankings
In 2022, Daniella Beckman's compensation ranked 2,191st out of 5,625 executives tracked by ExecPay. In other words, Beckman earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,191 out of 5,625 | 61st |
Division Manufacturing | 1,180 out of 3,053 | 61st |
Major group Chemicals And Allied Products | 507 out of 1,380 | 63rd |
Industry group Drugs | 467 out of 1,281 | 64th |
Industry Pharmaceutical Preparations | 340 out of 927 | 63rd |
Source: SEC filing on April 24, 2023.
Beckman's colleagues
We found two more compensation records of executives who worked with Daniella Beckman at Tango Therapeutics in 2022.